Old Web
English
Sign In
Acemap
>
Paper
>
Gliclazide treatment lowers serum ICAM-1 levels in poorly controlled type 2 diabetic patients
Gliclazide treatment lowers serum ICAM-1 levels in poorly controlled type 2 diabetic patients
2008
Nikolaos Papanas
Dimitrios N. Tziakas
Georgios K. Chalikias
D. Floros
Grigorios Trypsianis
Papadopoulou E
Alexandros Kortsaris
G. Symeonidis
E. Souliou
Efstratios Maltezos
D.I. Hatseras
Keywords:
Gliclazide
ICAM-1
Medicine
Diabetes mellitus
Internal medicine
Cardiology
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]